The impairments observed may explain poor decisions about COVID-prevention measures
The COVID-19 pandemic has tested our psychological limits. Some have been more affected than others by the stress of potential illness and the confusion of constantly changing health information and new restrictions. A new study finds the pandemic may have also impaired people’s cognitive abilities and altered risk perception, at a time when making the right health choices is critically important.
Scientists at McGill University and The Neuro (Montreal Neurological Institute-Hospital) surveyed more than 1,500 Americans online from April to June, 2020. Participants were asked to rate their level of worry about the COVID-19 pandemic and complete a battery of psychological tests to measure their basic cognitive abilities like processing and maintaining information in mind. The data were then compared to results of the same tests collected before the pandemic.
For example, participants completed an information processing test where they were asked to match pairs of digits and symbols according to a fixed rule. Participants’ risk attitudes were measured using an economic decision task where they made a series of hypothetical choices between a ‘certain’ option (e.g., a sure win of $75), and a ‘risky’ option (e.g. a 25 per cent chance of winning $0 and a 75 per cent chance of winning $100).
The researchers found that those who experienced more pandemic-related worry had reduced information processing speed, ability to retain information needed to perform tasks, and heightened sensitivity to the odds they were given when taking risks. The pandemic group performed more poorly on the simple cognitive tasks than the pre-pandemic group. Also, participants in the last wave of data collection showed slower processing speed, lower ability to maintain goals in mind, and were more sensitive to risk than those in the first wave.
Interestingly, the study found that pandemic worry predicted individuals’ tendency to distort described risk levels: underweighting likely probabilities and overweighting unlikely probabilities. This suggests that worry related to COVID may have affected people’s decision-making style, which is crucial as it may influence people’s decisions about getting a COVID-19 vaccine.
“The basic cognitive abilities measured here are crucial for healthy daily living and decision-making,” says Kevin da Silva Castanheira, a graduate student in McGill’s Department of Psychology and the study’s first author. “The impairments associated with worry observed here suggest that under periods of high stress, like a global pandemic, our ability to think, plan, an evaluate risks is altered. Understanding these changes are critical as managing stressful situations often relies on these abilities.”
“The impact of stress and of worry on cognitive function are well known, but are typically studied in the laboratory setting,” says Dr. Madeleine Sharp, a researcher and neurologist at The Neuro and study author. “Here, were able to extend these findings by studying the effects of a real-world stressor in a large sample. An important future direction will be to examine why some people are more sensitive than others to stress and to identify coping strategies that help to protect from the effects of stress.”
This study, published in the open access journal PLOS ONE, was funded with the help of a Canada Discovery Grant from the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council of Canada, the Canada Foundation for Innovation, Fonds de Recherche du Québec – Santé, and the G. W. Stairs Fund.
The Neuro – The Montreal Neurological Institute-Hospital – is a bilingual, world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical center in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders. In 2016, The Neuro became the first institute in the world to fully embrace the Open Science philosophy, creating the Tanenbaum Open Science Institute. The Montreal Neurological Institute is a McGill University research and teaching institute. The Montreal Neurological Hospital is part of the Neuroscience Mission of the McGill University Health Centre.